Detalhe da pesquisa
1.
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hepatology
; 78(2): 397-415, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37386786
2.
Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated.
J Hepatol
; 78(5): 989-997, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36702175
3.
Liver fibrosis for the dermatologist: a review.
Clin Exp Dermatol
; 48(4): 303-309, 2023 Mar 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36763770
4.
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.
J Hepatol
; 77(2): 353-364, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35367282
5.
A randomised placebo controlled trial of VSL#3® probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease.
BMC Gastroenterol
; 21(1): 144, 2021 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33794784
6.
Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension.
Gut
; 69(7): 1173-1192, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32114503
7.
National Early Warning Score Accurately Discriminates the Risk of Serious Adverse Events in Patients With Liver Disease.
Clin Gastroenterol Hepatol
; 16(10): 1657-1666.e10, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29277622
8.
Universal screening for alcohol misuse in acute medical admissions is feasible and identifies patients at high risk of liver disease.
J Hepatol
; 67(3): 559-567, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28756907
9.
Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials.
Clin Infect Dis
; 63(11): 1479-1481, 2016 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27553377
10.
The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α.
Liver Int
; 36(9): 1295-303, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-26950766
11.
Novel, nurse-led early postdischarge clinic is associated with fewer readmissions and lower mortality following hospitalisation with decompensated cirrhosis.
Frontline Gastroenterol
; 15(2): 124-129, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38486673
12.
Critical shortfalls in the management of PBC: Results of a UK-wide, population-based evaluation of care delivery.
JHEP Rep
; 6(1): 100931, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38089546
13.
Study protocol for a Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in Acute Variceal Bleeding (REACT-AVB trial).
BMJ Open Gastroenterol
; 11(1)2024 Mar 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38519049
14.
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.
Aliment Pharmacol Ther
; 59(2): 186-200, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37904314
15.
Improving Quality of Care for People with Hepatic Encephalopathy.
Br J Nurs
; 27(Sup3): S3, 2018 Feb 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29411992
16.
Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II).
Frontline Gastroenterol
; 14(3): 228-235, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37056320
17.
Primary biliary cholangitis: advances in understanding and management.
Br J Hosp Med (Lond)
; 83(3): 1-9, 2022 Mar 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35377202
18.
The National Audit of Primary Biliary Cholangitis (PBC) in the United Kingdom: Defining the Audit Dataset and Data Collection System.
Cureus
; 14(6): e25609, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35686197
19.
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group.
Lancet Gastroenterol Hepatol
; 7(8): 755-769, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35490698
20.
A Src family kinase inhibitor improves survival in experimental acute liver failure associated with elevated cerebral and circulating vascular endothelial growth factor levels.
Liver Int
; 31(8): 1222-30, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21745297